Cargando…

Serum endostatin levels are elevated in colorectal cancer and correlate with invasion and systemic inflammatory markers

BACKGROUND: Endostatin, a fragment of collagen XVIII, is an endogenous angiogenesis inhibitor with anti-tumour functions. However, elevated circulating endostatin concentrations have been found in several human cancers including colorectal cancer (CRC). METHODS: Serum endostatin levels were measured...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kantola, T, Väyrynen, J P, Klintrup, K, Mäkelä, J, Karppinen, S M, Pihlajaniemi, T, Autio-Harmainen, H, Karttunen, T J, Mäkinen, M J, Tuomisto, A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2014
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4200096/ https://www.ncbi.nlm.nih.gov/pubmed/25137019 http://dx.doi.org/10.1038/bjc.2014.456

Ejemplares similares

Stage-dependent alterations of the serum cytokine pattern in colorectal carcinoma
por: Kantola, T, et al.
Publicado: (2012)

Detailed analysis of inflammatory cell infiltration in colorectal cancer
por: Väyrynen, J P, et al.
Publicado: (2013)

Reply: Comment on 'Stage-dependent alterations of the serum cytokine pattern in colorectal carcinoma'
por: Kantola, T, et al.
Publicado: (2013)

Decreased preoperative serum 25-Hydroxyvitamin D levels in colorectal cancer are associated with systemic inflammation and serrated morphology
por: Väyrynen, Juha P., et al.
Publicado: (2016)

Decreased serum apolipoprotein A1 levels are associated with poor survival and systemic inflammatory response in colorectal cancer
por: Sirniö, Päivi, et al.
Publicado: (2017)

Clinical impact and network of determinants of tumour necrosis in colorectal cancer
por: Väyrynen, Sara A, et al.
Publicado: (2016)

Autoantibodies to endostatin in patients with breast cancer: correlation to endostatin levels and clinical outcome
por: Bachelot, T, et al.
Publicado: (2006)

Preoperative anemia in colorectal cancer: relationships with tumor characteristics, systemic inflammation, and survival
por: Väyrynen, Juha P., et al.
Publicado: (2018)

Alterations in serum amino-acid profile in the progression of colorectal cancer: associations with systemic inflammation, tumour stage and patient survival
por: Sirniö, Päivi, et al.
Publicado: (2018)

Putative anoikis resistant subpopulations are enriched in lymph node metastases and indicate adverse prognosis in colorectal carcinoma
por: Mattila, Taneli T., et al.
Publicado: (2022)

High-serum MMP-8 levels are associated with decreased survival and systemic inflammation in colorectal cancer
por: Sirniö, Päivi, et al.
Publicado: (2018)

Platelet count, aspirin use, and characteristics of host inflammatory responses in colorectal cancer
por: Väyrynen, Juha P., et al.
Publicado: (2019)

Endostatin expression in pancreatic tissue is modulated by elastase
por: Brammer, R D, et al.
Publicado: (2005)

Divergent expression of bacterial wall sensing Toll-like receptors 2 and 4 in colorectal cancer
por: Paarnio, Karoliina, et al.
Publicado: (2017)

Systemic inflammation is associated with circulating cell death released keratin 18 fragments in colorectal cancer
por: Sirniö, Päivi, et al.
Publicado: (2020)

Host-derived MMP-13 exhibits a protective role in lung metastasis of melanoma cells by local endostatin production
por: Fukuda, H, et al.
Publicado: (2011)

Endostatin expression in a pancreatic cell line is modulated by a TNFα-dependent elastase
por: Brammer, R D, et al.
Publicado: (2005)

Elevated serum matrix metalloproteinase 9 (MMP-9) concentration predicts the presence of colorectal neoplasia in symptomatic patients
por: Hurst, N G, et al.
Publicado: (2007)

Toll-like receptor 5 (TLR5) expression is a novel predictive marker for recurrence and survival in squamous cell carcinoma of the tongue
por: Kauppila, J H, et al.
Publicado: (2013)

Serum amyloid A is elevated in the serum of lung cancer patients with poor prognosis
por: Cho, W C S, et al.
Publicado: (2010)

Serum 20S proteasome is elevated in patients with renal cell carcinoma and associated with poor prognosis
por: de Martino, M, et al.
Publicado: (2012)

Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts
por: Huhtinen, K, et al.
Publicado: (2009)

Downregulation of serum metabolite GTA-446 as a novel potential marker for early detection of colorectal cancer
por: Hata, Tsuyoshi, et al.
Publicado: (2017)

Serum enterolactone concentrations are low in colon but not in rectal cancer patients
por: Tuomisto, Anne, et al.
Publicado: (2019)

Maspin is a marker for early recurrence in primary stage III and IV colorectal cancer
por: Snoeren, N, et al.
Publicado: (2013)

Molecular markers of response and toxicity to FOLFOX chemotherapy in metastatic colorectal cancer
por: Chua, W, et al.
Publicado: (2009)

Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer
por: Leitch, E F, et al.
Publicado: (2007)

Apoptosome-dependent caspase activation proteins as prognostic markers in Stage II and III colorectal cancer
por: Hector, S, et al.
Publicado: (2012)

C4.4A as a candidate marker in the diagnosis of colorectal cancer
por: Paret, C, et al.
Publicado: (2007)

CD133 expression is an independent prognostic marker for low survival in colorectal cancer
por: Horst, D, et al.
Publicado: (2008)

Expression of neutrophil gelatinase-associated lipocalin in colorectal neoplastic progression: a marker of malignant potential?
por: McLean, M H, et al.
Publicado: (2013)

Serum microRNA panel as biomarkers for early diagnosis of colorectal adenocarcinoma
por: Zheng, G, et al.
Publicado: (2014)

Elevated tumour interleukin-1β is associated with systemic inflammation: a marker of reduced survival in gastro-oesophageal cancer
por: Deans, D A C, et al.
Publicado: (2006)

RAD21 cohesin overexpression is a prognostic and predictive marker exacerbating poor prognosis in KRAS mutant colorectal carcinomas
por: Deb, S, et al.
Publicado: (2014)

Frequent mutations of KRAS in addition to BRAF in colorectal serrated adenocarcinoma
por: Stefanius, Karoliina, et al.
Publicado: (2011)

Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer
por: Matsumura, T, et al.
Publicado: (2015)

Serum matrix metalloproteinase 9 and colorectal neoplasia: a community-based evaluation of a potential diagnostic test
por: Wilson, S, et al.
Publicado: (2012)

Feasibility of proposed single-nucleotide polymorphisms as predictive markers for targeted regimens in metastatic colorectal cancer
por: Kim, J C, et al.
Publicado: (2013)

Elevated serum CXCL16 is an independent predictor of poor survival in ovarian cancer and may reflect pro-metastatic ADAM protease activity
por: Gooden, M J M, et al.
Publicado: (2014)

Serum sCD26 for colorectal cancer screening in family-risk individuals: comparison with faecal immunochemical test
por: Otero-Estévez, O, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_om3s2n0k3lmqrfd1ukk5vpg9u5